Syngene International Ltd
NSE:SYNGENE
Syngene International Ltd
NSE:SYNGENE
Price:
687.35 INR
-0.26%
Market Closed
Updated:
May 3, 2024
Syngene International Ltd
Operating Income
|
Syngene International Ltd
Operating Income Peer Comparison
Comparables:
DIVISLAB
SUVEN
DCAL
TARSONS
I
INNOVACAP
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Syngene International Ltd
NSE:SYNGENE
|
Operating Income
₹6.5B
|
CAGR 3-Years
19%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
Operating Income
₹20.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Suven Life Sciences Ltd
NSE:SUVEN
|
Operating Income
-₹1.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dishman Carbogen Amcis Ltd
NSE:DCAL
|
Operating Income
-₹141.2m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Tarsons Products Ltd
NSE:TARSONS
|
Operating Income
₹1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
I
|
Innova Captab Ltd
NSE:INNOVACAP
|
Operating Income
₹958.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Syngene International Ltd's Operating Income?
Operating Income
6.5B
INR
6.5B
INR
Based on the financial report for Dec 31, 2023, Syngene International Ltd's Operating Income amounts to 6.5B INR.
What is Syngene International Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
19%
19%
Over the last year, the Operating Income growth was 19%. The average annual Operating Income growth rates for Syngene International Ltd have been 19% over the past three years , 19% over the past five years .
You don't have any saved screeners yet
